Product Description The GMI LIPIDmix 36 (New Unit, June 2025) is GMI’s own proprietary lipid nanoparticle (LNP) formulation system, engineered for scalable mRNA and nucleic acid encapsulation at up to 36 mL/min with a 4-pump architecture. It includes 5 valve drives, a 16-port fraction collector, Clarity CDS (21 CFR Part 11 compliant) data station, and is designed for GMP-ready LNP manufacturing workflows. Backed by a 90-day warranty, with options to extend to 6 months or 1 year.
